PubMedCrossRef 2 Kamangar F, Dores GM, Anderson WF: Patterns of

PubMedCrossRef 2. Kamangar F, Dores GM, Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006,24(14):2137–2150.PubMedCrossRef 3. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003,349(23):2241–2252.PubMedCrossRef 4. Morita

M, Kuwano H, Ohno S, Sugimachi K, Seo Y, Tomoda H, Furusawa M, Nakashima T: Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Int J Cancer 1994,58(2):207–210.PubMedCrossRef 5. Zhang QX, Feng R, Zhang W, Ding Y, Yang JY, Liu GH: Role of Selleckchem MK-0518 stress-activated MAP kinase P38 in cisplatin- and DTT-induced apoptosis of the esophageal carcinoma cell line Eca109. World J Gastroenterol 2005,11(29):4451–4456.PubMed selleck kinase inhibitor 6. Wang CC, Mao WM, LING ZQ: [Expression of DNA methylation of ROCK inhibitor APC in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi 2011,14(9):719–722.PubMed 7. Lima SC, Hernandez-Vargas

H, Simao T, Durand G, Kruel CD, Le Calvez-Kelm F, Ribeiro PL, Herceg Z: Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Epigenetics 2011,6(10):1217–1227.PubMedCrossRef 8. Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y, Okamura T, Maehara Y: Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Int J Clin Oncol 2010,15(2):135–44.PubMedCrossRef 9. Silveira AP, Da SMF, Aoki S, Yamasaki LH, Rahal P, Silva AE: Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. Anticancer Res 2011,31(5):1685–1690.PubMed 10. Li X, Lin R, Li J: Epigenetic silencing of MicroRNA-375 Rutecarpine regulates PDK1 expression in esophageal cancer. Dig Dis Sci 2011,56(10):2849–2856.PubMedCrossRef

11. Ling ZQ, Li P, Ge MH, Zhao X, Hu FJ, Fang XH, Dong ZM, Mao WM: Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Int J Mol Med 2011,27(5):625–635.PubMedCrossRef 12. Qifeng S, Bo C, Xingtao J, Chuanliang P, Xiaogang Z: Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics. J Thorac Cardiovasc Surg 2011,141(3):808–814.PubMedCrossRef 13. Chang X, Yamashita K, Sidransky D, Kim MS: Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma. Int J Oncol 2011,38(4):1129–1135.PubMed 14.

Comments are closed.